320 related articles for article (PubMed ID: 3528312)
1. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Schwerer B
J Invest Dermatol; 1986 May; 86(5):529-34. PubMed ID: 3528312
[TBL] [Abstract][Full Text] [Related]
2. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
Schwerer B; Meeker HC; Sersen G; Levis WR
Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
[TBL] [Abstract][Full Text] [Related]
3. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
[TBL] [Abstract][Full Text] [Related]
4. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae.
Young DB; Dissanayake S; Miller RA; Khanolkar SR; Buchanan TM
J Infect Dis; 1984 Jun; 149(6):870-3. PubMed ID: 6376654
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterial carbohydrate antigens for serological testing of patients with leprosy.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Brennan PJ; Fried P
J Infect Dis; 1987 Nov; 156(5):763-9. PubMed ID: 3116103
[TBL] [Abstract][Full Text] [Related]
6. ELISA detection of IgM antibodies against phenolic glycolipid-I in the management of leprosy: a comparison between laboratories.
Meeker HC; Levis WR; Sersen E; Schuller-Levis G; Brennan PJ; Buchanan TM
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):530-9. PubMed ID: 3546543
[TBL] [Abstract][Full Text] [Related]
7. IgM anti-phenolic glycolipid I and IgG anti-10-kDa heat shock protein antibodies in sera and immune complexes isolated from leprosy patients with or without erythema nodosum leprosum and contacts.
Rojas RE; Demichelis SO; Sarno EN; Segal-Eiras A
FEMS Immunol Med Microbiol; 1997 Sep; 19(1):65-74. PubMed ID: 9322070
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
[TBL] [Abstract][Full Text] [Related]
9. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
Brett SJ; Draper P; Payne SN; Rees RJ
Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
[TBL] [Abstract][Full Text] [Related]
10. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.
Andreoli A; Brett SJ; Draper P; Payne SN; Rook GA
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
[TBL] [Abstract][Full Text] [Related]
12. IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: subclass distribution and relation to disease activity.
Schwerer B; Chujor CS; Bernheimer H; Radl J; Haaijman JJ; Meeker HC; Sersen G; Levis WR
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):202-11. PubMed ID: 2676273
[TBL] [Abstract][Full Text] [Related]
13. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
[TBL] [Abstract][Full Text] [Related]
14. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G response against 10-kDa and 65-kDa heat-shock proteins in leprosy patients and their household contacts.
Rojas RE; Segal-Eiras A
FEMS Immunol Med Microbiol; 1996 Oct; 15(4):189-98. PubMed ID: 8908480
[TBL] [Abstract][Full Text] [Related]
16. Defective monocyte chemotaxis in active lepromatous leprosy.
Schuller-Levis G; Harris D; Cutler E; Meeker HC; Haubenstock H; Levis WR
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):267-72. PubMed ID: 3298473
[TBL] [Abstract][Full Text] [Related]
17. The serological response to the phenolic glycolipid of Mycobacterium leprae in Australian and Nepali leprosy patients.
Britton WJ; Garsia RJ; Basten A
Aust N Z J Med; 1987 Dec; 17(6):568-73. PubMed ID: 3328975
[TBL] [Abstract][Full Text] [Related]
18. Association of IgG and IgM antibodies to phenolic glycolipid-1 antigen of Mycobacterium leprae with disease parameters in multibacillary leprosy patients.
Lyons NF; Shannon EJ; Ellis BP; Naafs B
Lepr Rev; 1988 Mar; 59(1):45-52. PubMed ID: 3294540
[No Abstract] [Full Text] [Related]
19. Levels of IgG subclasses in active and inactive cases in the disease spectrum of leprosy.
Beuria MK; Parkash O; Joshi B; Mohanty KK; Katoch K; Sengupta U
Int Arch Allergy Immunol; 1998 Jan; 115(1):61-6. PubMed ID: 9430497
[TBL] [Abstract][Full Text] [Related]
20. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
